Publication|Articles|December 8, 2023
- Pharmaceutical Commerce - December 2023
- Volume 18
- Issue 6
Pharmaceutical Commerce - December 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Commerce December 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 2 years ago
Patients are the Priorityabout 2 years ago
Brand Evolution and Engagementabout 2 years ago
A Supply Chain Overhaulabout 2 years ago
Continued Affordability Challenges in the Offingabout 2 years ago
Who Moved My Prescription?about 2 years ago
Transforming the Patient Hub into a Hub of Patient Centricityabout 2 years ago
Navigating the Biosimilars Marketplaceabout 2 years ago
An Outlook on Data-Powered Patient Supportabout 2 years ago
Prescribing Resilience: Third-Party Risks and Pharmaabout 2 years ago
The Business Case for RWENewsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Novartis’ $23 Billion Manufacturing Investment Anchors Industry Shift Toward US Onshoring
2
Trade & Channel Strategies 2025: The $405 Billion Patent Cliff Demands Partnership and Adaptive Market Access Strategies
3
The Key to Connecting with Patients: Pharma's Market Access Transformation
4
Why Specialty Drugs Dominate Spending, and the Frontline Roles Shaping Patient Access
5
